Posterior Wall Osteotomy for Old Acetabular Fracture

NCT ID: NCT03193840

Last Updated: 2017-06-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-06-12

Study Completion Date

2019-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Posterior wall osteotomy would be conducted to manage the old acetabular fracture. The outcome was reviewed to assess the feasibility of the surgical procedure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

More and more patients with old acetabular fracture were admitted in our institution during the past years. There is little literature especially depicts the therapeutic principle of the kind of damage. Posterior wall osteotomy would be conducted to eliminate the fragments or callus from the hip joint. Then, the deformed healing acetabulum could become mobile and the reduction may be achieved. However, the surgical procedure is technique demanding and some intraoperative risk may be accompanied.

Surgical time, blood loss, complication and fracture healing would be reviewed to assess the feasibility of the surgical procedure. The function outcome is evaluated with HHS score at the follow up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgical Procedure, Unspecified

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

old acetabular fracture

posterior wall osteotomy would be conducted for thr patient with displaced acetabular fracture without surgical treatment over three weeks.

Group Type EXPERIMENTAL

posterior wall osteotomy

Intervention Type PROCEDURE

posterior wall osteotomy is conducted through Kocher-Langenbeck approach.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

posterior wall osteotomy

posterior wall osteotomy is conducted through Kocher-Langenbeck approach.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* acetabular fracture
* no surgical procedure has been obtained over 3 weeks
* deformed healing
* receive posterior wall osteotomy
* completed more than one year follow-up

Exclusion Criteria

* accompanied with other fracture
* pathological fracture
* reject the posterior wall osteotomy
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hebei Medical University Third Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zhiyong Hou

Role: STUDY_CHAIR

Third Hospital of Hebei Medical University Department of Orthopaedic Surgery

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hebei Medical University Third Hospital

Shijiazhuang, Hebei, China

Site Status RECRUITING

Zhiyong Hou

Shijiazhuang, Hebei, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Zhiyong Hou

Role: CONTACT

+8618533112800

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Zhiyong Hou, M.D

Role: primary

+8618533112800

Zhiyong Hou, M.D

Role: primary

+8618533112800

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ZRP1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.